ALS – media

Next Generation Drug Could Treat Inherited Form of ALS in Animal Models

New research funded by the NIH found that a second-generation drug, when injected in rodents, deferred signs of amyotrophic lateral sclerosis (ALS).
- Source: ScienceDaily
- 545
- August 2, 2018
ALS Clinical Trial Researches
Investigational Therapy For ALS Extends Patient Survival

In the United States alone, there are an estimated 20,000 people living with amyotrophic lateral sclerosis (ALS), also called as Lou Gehrig's disease. The fatal disease destroys the nerve cells which control breathing, walking, and eating. Very few people survive more than three years after being diagnosed.
- Source: EurekAlert
- 532
- July 19, 2018
ALS Lou Gehrig's Disease Researches
Amyotrophic Lateral Sclerosis Patients Found New Hope

Lou Gehrig disease which has no cure is finally seeing a ray of hope by Tel Aviv University researchers. The disease also called Amyotrophic lateral sclerosis (ALS) a neurodegenerative issue which causes muscles to atrophy and produces permanent disability in patients. The investigators say they may have found the basis of what could become a treatment for the devastating disease.
- Source: Ddu
- 473
- May 28, 2018
ALS Researches
Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS

Sangamo Therapeutics, Inc. and Pfizer Inc. announced a collaboration for the development of a potential gene therapy using zinc finger protein transcription factors to treat amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) linked to mutations of the C9ORF72 gene.
- Source: Prnewswire
- 447
- January 9, 2018
ALS FTLD Market Views neurodegenerative disease
Sangamo partners with Pfizer to develop gene therapy for ALS

Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS
- Source: Reuters
- 501
- January 4, 2018
ALS Company Insight FDA Gene therapy Pfizer

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.